Diligence memo · auto-generated · as of July 2, 2026

Respicardia, Inc.

Respicardia, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Respicardia, Inc. operates in Other Health Care, based in Minnetonka.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Respicardia, Inc. has raised $92M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $27M on 2010-08-09.

Most recent recorded round closed around 2017-12-04.

Valuation (modeled)modeled

Provath models Respicardia, Inc. at approximately $443M (range $47M–$1.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.99× the median modeled value of Series B Other Health Care companies in 2016–2018 (74 peers) — value vs value, same stage and era. Within the normal band (99% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 15 months.

Last raise 8.6 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 3.9× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 96% of Other Health Care peers (5377 compared).

Modeled value ranks above 93% of those peers.

Closest niche peers: Podicare Services, Inc., COTA, Inc., Fresenius Medical Care - Meridian Health System, LLC, Headspace, Inc., Spine Holdings LLC.

Peoplefiled

17 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.